Shusuke Akamatsu

15PUBLICATIONS
50CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsiesMedical mycologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 14, 2026
Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiency.

|Apr 25, 2025
Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC Study.

Masaki Shiota, Shota Nemoto, Ryo Ikegami

|Jan 06, 2025
Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial Cancer.

Toru Sakatani, Takayuki Sumiyoshi, Yuki Kita

|Jul 19, 2024
A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity.

Hiroshi Fujiwara, Masashi Kubota, Yu Hidaka

|Mar 01, 2024
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort.

Masashi Kato, Masaki Shiota, Takahiro Kimura

|Aug 02, 2023
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study.

Leandro Blas, Masaki Shiota, Hideaki Miyake

Pageof 3

Frequent Collaborators

8 joint publications

Takashi Kobayashi

3 joint publications

Masaki Shiota

3 joint publications

Wataru Obara

2 joint publications

Kojiro Ohba